Your browser doesn't support javascript.
loading
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.
Lacy, Stuart E; Barrans, Sharon L; Beer, Philip A; Painter, Daniel; Smith, Alexandra G; Roman, Eve; Cooke, Susanna L; Ruiz, Camilo; Glover, Paul; Van Hoppe, Suzan J L; Webster, Nichola; Campbell, Peter J; Tooze, Reuben M; Patmore, Russell; Burton, Cathy; Crouch, Simon; Hodson, Daniel J.
Afiliação
  • Lacy SE; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Barrans SL; Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.
  • Beer PA; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Painter D; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Smith AG; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Roman E; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Cooke SL; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Ruiz C; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Glover P; Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.
  • Van Hoppe SJL; Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.
  • Webster N; Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.
  • Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Tooze RM; Section of Experimental Haematology, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom.
  • Patmore R; Queen's Centre for Oncology and Haematology, Castle Hill Hospital, Cottingham, United Kingdom; and.
  • Burton C; Haematological Malignancy Diagnostic Service, St. James's Institute of Oncology, Leeds, United Kingdom.
  • Crouch S; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Hodson DJ; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Blood ; 135(20): 1759-1771, 2020 05 14.
Article em En | MEDLINE | ID: mdl-32187361
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Mutacional de DNA / Linfoma Difuso de Grandes Células B / Sequenciamento do Exoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Análise Mutacional de DNA / Linfoma Difuso de Grandes Células B / Sequenciamento do Exoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Europa Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos